J.B. Chemicals & Pharmaceuticals Lt (Delisted) share news and announcements
BSE: 506943Pharmaceuticals & Biotechnology
Last traded ₹2,408.90 on 16 Jul 2026
Delisted on 12 Oct 2026.
J.B. Chemicals & Pharmaceuticals Lt share news and announcements
1,922 announcements, routine notices left out, newest first. Page 37 of 39.
Dec 2010
2 Dec · J.B. Chemicals receives US FDA approval for Diclofenace Sodium Tablets
Oct 2010
Sep 2010
30 Sep · Board meeting
To approve and take on record the unaudited financial results for the quarter/half year ending on September 30, 2010.30 Sep · Business
Compensation committee of the board of directors of the Company has, on September 28, 2010, issued and allotted 42,025 equity shares of face value of Rs.2/- each of (29,150 shares at a premium of Rs. 61 per share, and 12,375 shares at a premium of Rs. 82 per share and 500 shares at a premium of Rs. 93 per share) to certain employees against the exercise of options granted to them pursuant to Employees Stock Option Scheme of the company. The issued and paid up capital has thus gone up from to 8,43,96,201 equity shares of Rs. 2 each to 8,44,38,225 equity shares of Rs. 2 each.29 Sep · Allotment of equity shares
Compensation Committee of the board of directors of the Company on September 28, 2010, has issued and allotted 42,025 equity ....
Aug 2010
13 Aug · Business
Compensation Committee of the Board of Directors of the Company has, on August 10, 2010 issued and allotted 27,075 equity shares of face value of Rs. 2 each (15,825 shares at a premium of Rs.61 per share and 11,250 shares at a premium of Rs. 82 per share) to certain employees against the exercise of options granted to them pursuant to Employees Stock Option Scheme of the Company. The issued and paid up capital has thus gone up from to 8,43,69,125 equity shares of Rs. 2 each to 8,43,96,200 equity shares of Rs. 2 each.10 Aug · Outcome of Compensation Committee Meeting
Compensation committee of the board of directors of the Company on August 10, 2010, has issued and allotted 27,075 equity shares ....
Jul 2010
26 Jul · Management
Mr. Vishnu D Patel has ceased to be a director of the Company w.e.f. July 23, 2010 as he did not seek re-election at the annual ....26 Jul · Management
Board of Directors has appointed Dr. Satyanarain Agarwala as an additional director of the Company, on July 24, 2010. Further Dr. Satyanarain Agarwala was earlier appointed as an alternate director to Mr. Vishnu D. Patel. Mr. Vishnu D. Patel ceased to be a director of the Company w.e.f. July 23, 2010, being the date of last annual general meeting, as he did not seek re-election.26 Jul · Management
Board of Directors has appointed Dr. Satyanarain Agarwala as an additional director of the Company, on July 24, 2010. Further ....13 Jul · Board meeting
To approve and take on record unaudited financial results for the quarter ended on June 30, 2010.7 Jul · Dividend
Dividend for the year 2009-10, if declared at the ensuing annual general meeting scheduled on July 23, 2010, will be paid on July 30, 2010, i.e. electronic credit in case of shares held in dematerialized form will be effected on July 30, 2010 in all eligible cases and dividend cases and dividend warrants will be mailed on July 30, 2010 in rest of the cases.7 Jul · Dividend
Dividend for the year 2009-10, if declared at the ensuing annual general meeting scheduled on July 23, 2010, will be paid on ....
Jun 2010
30 Jun · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 19, 2010 to July 23, 2010 (both days ....29 Jun · Corporate action
Company has decided to close the Register of Member and Share Transfer Books from July 19, 2010 to July 23, 2010 (both days inclusive) for the purpose of Annual General Meeting and Declaration of Dividend.
May 2010
11 May · Business
Compensation committee of the board of directors of the Company has, on May 10, 2010, issued and allotted 16,425 equity shares of face value of Rs.2/- each of the Company to various employees against exercise of options granted to them on April 01, 2004 at exercise price of Rs.63/- per share. The issued and paid up capital has thus gone up from 8,43,52,700 shares of Rs.2/- each to 8,43,69,125 equity shares of Rs.2/- each.11 May · Outcome of Compensation Committee Meeting
Compensation Committee of the board of directors of the Company has, on May 10, 2010, issued and allotted 16,425 equity shares ....6 May · Dividend
Board of Director at its meeting held on May 05, 2010 has recommended a dividend of Rs. 2 (100%) per equity share of Rs. 2. This together with dividend distribution tax will absorb Rs. 1967.62 lacs.6 May · Dividend
Board of Directors of the Company at it meeting held on May 05, 2010, inter alia, has recommended dividend @ Rs 2.OO (100%) ....
Apr 2010
28 Apr · Allotment of Equity Shares
Compensation committee of the board of directors of the company has, on April 27, 2010, issued and allotted 26,350 equity shares of face value of Rs.2/- each of the Company to various employees against exercise of options granted to them on April 01, 2004 at exercise price of Rs.63/- per share. The issued and paid up capital has thus gone up from 8,43,26,350 shares of Rs.2/- each to 8,43,52,700 equity shares of Rs.2/- each.28 Apr · Allotment of Equity Shares
Compensation committee of the board of directors of the Company has, on April 27, 2010, issued and allotted 26,350 equity shares ....16 Apr · Board meeting
To consider and approve annual audited financial results for the year ended on March 31, 2010. Further, at the above referred meeting the Board of Directors would also consider recommendation of dividend for the year 2009-10.16 Apr · Board meeting
Meeting of the Board of Directors of the Company will be held on May 05, 2010, to consider and approve annual audited financial ....
Jan 2010
28 Jan · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release, dated January 28, 2010, with respect to unaudited financial results for the quarter ended on December 31, 2009. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Jan · Board meeting
Meeting on 28 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
26 Oct · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release, dated October 26, 2009, on unaudited financial results for the quarter ended on September 30, 2009. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Oct · Board meeting
To approve and take on record unaudited financial results for the quarter/half year ended on September 30, 2009.
Aug 2009
28 Aug · Business
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated August 28, 2009 regarding "Jb Chemicals & Pharmaceuticals Ltd. (JBCPL) announces the receipt of US FDA Approval to the it's Abbreviated New Drug Application (ANDA) for Cetirizine Hydrocholoride (anti-allergic) 5 mg. and 10 mg. Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
31 Jul · Meeting
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the minutes of the Annual General Meeting of the members of the Company held on July 13, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jul · Business
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the press release on Unaudited Financial Results for the quarter ended on June 30, 2009. A copy of the press release be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jul · Meeting
Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that, at the Annual General Meeting held on July 13, 2009, the members of the company have unanimously: 1) approved financial statements for the year ended on March 31, 2009 and report of the auditors and board of directors thereon; 2) approved declaration of dividend at the rate of Re.1 per equity share of face value of Rs.2; 3) approved the re-appointment of Mr. Bansidhar S. Mehta, Mr. Durgass Dass Chopra, Mr. Rajiv Mody & Mr. Bharat P. Mehta as directors of the company; and 4) re-appointed the auditors to hold office until the conclusion of next Annual General Meeting.
Jun 2009
29 Jun · Board meeting
Meeting on 21 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”15 Jun · Meeting
Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange the Notice of the Annual General Meeting of the members of the Company to be held on July 13, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.